Summary
Join a cutting-edge research team at Karolinska Institutet focused on translational research in cancer treatment. This PhD position offers an exciting opportunity to work on integrative bioinformatics for breast cancer using mass spectrometry-based proteomics.
PhD Scholarship in Bioinformatics: Clinical Breast Cancer Proteomics at Karolinska Institutet, Stockholm, Sweden
Designation
PhD Student in Bioinformatics
Research Area
Clinical Breast Cancer Proteomics within the Cancer Proteomics Mass Spectrometry research group
Location
Karolinska Institutet, Stockholm, Sweden
Eligibility/Qualification
| Criteria | Requirements |
|---|---|
| General Eligibility | 1. Master’s degree or equivalent. 2. 240 credits (60 at an advanced level) or equivalent knowledge from other means. |
| Specific Eligibility | Proficiency in English equivalent to English B/English 6 at Swedish upper secondary school. |
| Required Qualifications | – Master of Science (or equivalent) in bioinformatics, biology, medicine, computer science, or related fields. – Documented experience in bioinformatics data analysis. |
| Programming Skills | Proficiency in Python and/or R (or equivalent). |
| Other Skills | – Knowledge of statistical methods. – Understanding of cell and molecular biology. – Fluency in written and spoken English. |
Job Description
This PhD position involves:
- Analyzing and integrating omics data from clinical breast cancer cohorts, with a focus on triple-negative breast cancer (TNBC).
- Applying established data analysis pipelines and developing new computational strategies.
- Collaborating within a multidisciplinary team to further cancer research and improve treatment outcomes.
How to Apply
Interested candidates should submit their applications through the Varbi recruitment system. The application must include:
- A personal letter
- Curriculum vitae
- Documentation of relevant skills and experiences
- Certifications of eligibility requirements
Last Date to Apply
May 13, 2026
This scholarship is an exceptional opportunity to be part of a leading research initiative that aims to make a significant impact in the field of cancer research and treatment.
